Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation

IMPORTANCE: Patients with nonvalvular atrial fibrillation at risk of stroke should receive oral anticoagulants (OAC). However, approximately 1 in 8 patients in the Global Anticoagulant Registry in the Field (GARFIELD-AF) registry are treated with antiplatelet (AP) drugs in addition to OAC, with or w...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JAMA Netw Open
Main Authors: Fox, Keith A. A., Velentgas, Priscilla, Camm, A. John, Bassand, Jean-Pierre, Fitzmaurice, David A., Gersh, Bernard J., Goldhaber, Samuel Z., Goto, Shinya, Haas, Sylvia, Misselwitz, Frank, Pieper, Karen S., Turpie, Alexander G. G., Verheugt, Freek W. A., Dabrowski, Elizabeth, Luo, Kaiyi, Gibbs, Liza, Kakkar, Ajay K.
Format: Artigo
Sprog:Inglês
Udgivet: American Medical Association 2020
Fag:
Original Investigation
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7137686/
https://ncbi.nlm.nih.gov/pubmed/32101311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2020.0107
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker